Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceutica...

FDA Recall #D-0326-2021 — Class I — March 17, 2021

Recall #D-0326-2021 Date: March 17, 2021 Classification: Class I Status: Terminated

Product Description

Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 38935, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807, NDC 62332-087-30

Reason for Recall

Labeling: Label-mixup

Recalling Firm

Alembic Pharmaceuticals Limited — Tajpura, N/A

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

12288 bottles

Distribution

Nationwide within the United States

Code Information

Lot #: 1905005661, Exp March 2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls